ORIGINAL ARTICLE
Rhabdomyosarcoma in children in the light of isotope ratio mass spectrometry
Publication date: 2016-02-05
Pol J Pathol 2015;66(4):383-388
KEYWORDS
ABSTRACT
Rhabdomyosarcoma is the third most common solid tumor in children and the most common soft tissue sarcoma in this age group. However, 5-year survival is only observed in approximately 70% of cases, and the prognosis for patients with progressive disease is still poor. The authors hypothesize that the still unidentified differences in embryonal and alveolar tumor biology reflect the complex chemical reactions occurring during cell growth and metabolism and may be pursued in isotopic fractionation processes. Presented herein is the first evaluation of the nitrogen and carbon isotope ratio using isotope ratio mass spectrometry in the two major rhabdomyosarcoma histologic types. 15N enrichment was found in tumor tissues of embryonal histological type. The obtained result may indicate that individual patient considerations such as isotope ratio, in addition to widely accepted prognostic factors, may facilitate patient classification in terms of risk groups.
REFERENCES (45)
1.
Gurney JG, Severson RK, Davis S, et al. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer 1995; 75: 2186-2195.
2.
Ries LA, Kosary CL, Hankey BF, et al. (eds.). SEER Cancer Statistics Review, 1973-1996. National Cancer Institute, Bethesda 1999.
3.
Qalman S, Coffin C, Newton W, et al. Intergroup Rhabdomyosarcoma study: Update for Pathologists. Pediatr Dev Pathol 1998; 1: 550-561.
4.
Crist W, Kun L. Common solid tumors of childhood. N Engl J Med 1991, 324: 461-471.
5.
Parham DM, Ellison DA. Rhabdomyosarcomas in adults and children: an update. Arch Pathol Lab Med 2006; 130: 1454-1465.
6.
Pfeifer JD, Hill DA, O’Sullivan MJ, Dehner LP. Diagnostic gold standard for soft tissue tumors: morphology or molecular genetics? Histopathology 2000; 37: 485-500.
7.
Qualman S, Lynch J, Bridge J, et al. Prevalence and clinical impact of anaplasia in childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. Cancer 2008; 113: 3242-3247.
8.
Davicioni E, Anderson MJ, Finckenstein FG, et al. Molecular classification of rhabdomyosarcoma – genotypic and phenotypic determinants of diagnosis: a report from the Children’s Oncology Group. Am J Pathol 2009; 174: 550-564.
9.
Dumont SN, Lazar AJ, Bridge JA, et al. PAX3/7-FOXO1 fusion status in older rhabdomyosarcoma patient population by fluorescent in situ hybridization. J Cancer Res Clin Oncol 2012; 138: 213-220.
10.
Chen X, Stewart E, Shelat AA, et al. Targeting oxidative stress in embryonal rhabdomyosarcoma. Cancer Cell 2013; 24: 710-724.
11.
Koufos A, Hansen MF, Copeland NG, et al. Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. Nature 1985; 316: 330-334.
12.
Krsková L, Mrhalová M, Sumerauer D, et al. Rhabdomyosarcoma: molecular diagnostics of patients classified by morphology and immunohistochemistry with emphasis on bone marrow and purged peripheral blood progenitor cells involvement. Virchows Arch 2006; 448: 449-458.
13.
Kelly KM, Womer RB, Sorensen PH, et al. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol 1997; 15: 1831-1836.
14.
Pappo AS, Anderson JR, Crist WM, et al. Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol 1999; 17: 3487-3493.
15.
Mazzoleni S, Bisogno G, Garaventa A, et al. Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma. Cancer 2005; 104: 183-190.
16.
Martinez del Rio C, Wolf N, Carleton SA, Gannes LZ. Isotopic ecology ten years after a call for more laboratory experiments. Biological Reviews 2009; 84: 91-111.
17.
O’Connell TC, Kneale CJ, Tasevska N, Kuhnle GGC. The Diet-Body Offset in Human Nitrogen Isotopic Values: A Controlled Dietary Study. Am J Physical Anthropol 2012; 149: 426-434.
18.
Reitsema L. Beyond diet reconstruction: stable isotope applications to human physiology, health, and nutrition. Am J Hum Biol 2013; 25: 445-456.
19.
Kurle CM. Stable-isotope ratios of blood components from captive northern fur seals (Callorhinus ursinus) and their diet: applications for studying the foraging ecology of wild otariids. Can J Zool 2002; 80: 902-909.
20.
Feliecetti LA, Schwartz CC, Rye RO, et al. Use of sulfur and nitrogen stable isotopes to determine the importance of whitebark pine nuts to Yellowstone grizzly bears. Can J Zool 2003; 81: 763-770.
21.
Carter JF, Barwick VJ (ed.). Good practice guide for isotope ratio mass spectrometry. FIRMS 2011; 2.
23.
Peterson BJ, Fry B. Stable isotopes in ecosystem studies. Attn Rev Ecol Syst 1987; 8: 293-320.
24.
Sandberg PA, Loudon JE, Sponheimer M. Stable isotope analysis in primatology: a critical review. Am J Primatol 2012; 74: 969-989.
25.
Mekota AM, Grupe G, Ufer S, Cuntz U. Serial analysis of stable nitrogen and carbon isotopes in hair: monitoring starvation and recovery phases of patients suffering from Anorexia nervosa. Rapid Commun Mass Spectrom 2006; 20: 1604-1610.
26.
Boriosi JP, Maki DG, Yngsdal-Krenz RA, et al. Changes in breath carbon isotope composition as a potential biomarker of inflammatory acute phase response in mechanically ventilated pediatric patients. J Anal At Spectrom 2014; 29: 599-605.
27.
Ornstein DK, Gillespie JW, Paweletz CP, et al. Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis 2000; 21: 2235-2242.
28.
Rozanski K, Johnsen SJ, Schotterer U, Thompson LG. Reconstruction of past climates from stable isotope records of palaeprecipitation preserved in continental archives. Hydrol Sci J 1997; 42: 725-745.
29.
McCarroll D, Loader NJ. Stable isotopes in tree rings. Quaternary Science Reviews 2004; 23: 771-801.
30.
Crist W, Gehan EA, Ragab AH, et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995; 13: 610-630.
31.
Fuller BT, Fuller JL, Sage NE, et al. Nitrogen balance and why you’re not what you eat during nutritional stress. Rapid Commun Mass Spectrom 2005; 19: 2497-2506.
32.
Sulzman EW. Stable isotope chemistry and measurement: a primer. Stable isotopes in ecology and environmental science (Michener R, Lajtha K (eds.). 2nd ed. Blackwell Publishing, Boston 2007; 1-21.
33.
Macko S, Fogel M, Hare PE, Hoering TC. Isotopic fractionation of nitrogen and carbon in the synthesis of amino acids by microorganisms. Chemical Geology (Isotope Geoscience Section) 1987; 65: 79-92.
34.
Macko S, Fogel M, Engel MH, Hare PE. Kinetic fractionation of stable nitrogen isotopes during amino acid transamination. Geochimica et Cosmochimica Acta 1986, 50: 2143-2146.
35.
Metges CC, Petzke KJ, Hennig U. Gas chromatography / combustion / isotope ratio mass spectrometric comparison of Nacetyl-and N-pivaloyl amino acid esters to measure 15N isotopic abundances in physiological samples: a pilot study on amino acid synthesis in the upper gastrointestinal tract. J Mass Spectrometry 1996; 31: 367-376.
36.
Sorensen PH, Lynch JC, Qualman SJ, et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children’s oncology group. J Clin Oncol 2002; 20: 2672-2679.
37.
Missiaglia E, Williamson D, Chisholm J, et al. PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. J Clin Oncol 2012; 30: 1670-1677.
38.
Sartori F, Alaggio R, Zanazzo G, et al. Results of a prospective minimal disseminated disease study in human rhabdomyosarcoma using three different molecular markers. Cancer 2006, 106: 1766-1775.
39.
Shern JF, Chen L, Chmielecki J, et al. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. Cancer Discov 2014; 4: 216-231.
40.
Williamson D, Missiaglia E, de Reyniès A, et al. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol 2010; 28: 2151-2158.
41.
Merlino G, Helman LJ. Rhabdomyosarcoma – working out the pathways. Oncogene 1999; 18: 5340-5348.
42.
Barr FG, Qualman SJ, Macris MH, et al. Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions. Cancer Res 2002; 62: 4704-4710.
43.
Duan F, Smith LM, Gustafson DM, et al. Genomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: a report from the Children’s Oncology Group. Genes Chromosomes Cancer 2012; 51: 662-674.
44.
Breneman JC, Lyden E, Pappo AS, et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma – a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 2003; 21: 78-84.
45.
Mandell L, Ghavimi F, LaQuaglia M, et al. Prognostic significance of regional lymph node involvement in childhood extremity rhabdomyosarcoma. Med Pediatr Oncol 1990; 18: 466-471.
| eISSN: | 2084-9869 |
| ISSN: | 1233-9687 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
